ESC 365 - Novel strategies to treat atrial fibrillation: Much ado about nothing?

ESC Premium Access

Novel strategies to treat atrial fibrillation: Much ado about nothing?

Session: Atrial fibrillation - Not all quiet on the molecular front

Topic: Cardiac Diseases

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 presentations

0 follower

3 more presentations in this session

Na+ channel blockers in AF - New trends or old wine in new wineskins?

Speaker: Professor S. Sossalla (Regensburg, DE)

Epicardial fat - A new player in the pathophysiology of atrial fibrillation?

Speaker: Professor S. Hatem (Paris, FR)

Life at superresolution - Atrial-specific Ca2+ signaling mechanisms and hypertrophic remodeling.

Speaker: Professor S. Lehnart (Goettingen, DE)

Access the full session

Atrial fibrillation - Not all quiet on the molecular front

Speakers: Doctor R. Wijesurendra, Professor S. Sossalla, Professor S. Hatem, Professor S. Lehnart

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Related content

ESC Premium Access

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

27 August 2021

ESC Premium Access

Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

27 August 2021

ESC Premium Access

A case of cardiac amyloidosis initially mis-diagnosed as BRASH syndrome.

27 August 2021

ESC 365 is supported by